Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is a single-center, single-arm, prospective clinical trial designed to evaluate the efficacy of local excision followed by postoperative chemoradiotherapy in patients with early-stage low/ultra-low rectal cancer. The study plans to enroll 60 patients with T1-2N0M0 low/ultra-low rectal cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub starszy
- •Potwierdzony biopsją rak odbytnicy (adenocarcinoma)
- •Nowotwór zlokalizowany nie dalej niż 8 cm od otworu odbytniczego
- •Wczesny stadium (T1-2N0M0) - mały guz bez przerzutów do węzłów i narządów
- •Silne pragnienie zachowania naturalnego odbytnika
- •Lekarz stwierdził możliwość bezpiecznego małego wycięcia
- •Brak przeciwwskazań do chemioterapii i promieniowania
✗ Disqualifies
- •Niezgoda na uczestnictwo w badaniu
- •Zaburzenia poznawcze lub problemy psychiatryczne
- •Uznanie przez lekarza za nieodpowiedniego do badania
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 75 Years
- Last updated (source)
- August 3, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
The Fourth Hospital of Hebei Medical University
Shijiazhuang, China
Trial contact
chaoxi Zhou
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/4/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.